(Q39576769)

13 September 2017

Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells (English)

1 reference

Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics

13 September 2017

0 references

0 references

1 reference

Lucienne Juillerat-Jeanneret

series ordinal

4

object named as

Lucienne Juillerat-Jeanneret

1 reference

13 September 2017

Davide Staedler

1

1 reference

PubMed ID

21400027

13 September 2017

Elita Idrizi

series ordinal

2

1 reference

PubMed ID

21400027

13 September 2017

Blanka Halamoda Kenzaoui

series ordinal

3

1 reference

13 September 2017

13 March 2011

1 reference

Cancer Chemotherapy and Pharmacology

13 September 2017

1 reference

13 September 2017

68

1 reference

13 September 2017

5

1 reference

13 September 2017

1161-1172

1 reference

https://scigraph.springernature.com/pub.10.1007/s00280-011-1596-x

13 September 2017

0 references

cites work

First-line chemotherapy with or without biologic agents for metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Oxidative DNA base damage in MCF-10A breast epithelial cells at clinically achievable concentrations of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Quercetin pharmacokinetics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF7 human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Distinctive antioxidant and antiinflammatory effects of flavonols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

The antioxidant quercetin inhibits cellular proliferation via HIF-1-dependent induction of p21WAF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Glutathione transferases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

21 January 2018

Glutathione transferases

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

The glutathione-related detoxification pathway in the human breast: a highly coordinated system disrupted in the tumour tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

The effect of quercetin on topotecan cytotoxicity in MCF-7 and MDA-MB 231 human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Dietary quercetin combining intratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

The effect of flavonoid derivatives on doxorubicin transport and metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Heterogeneity of human glioblastoma: glutathione-S-transferase and methylguanine-methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

The comet assay for DNA damage and repair: principles, applications, and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Glutathione S-transferases in wild-type and doxorubicin-resistant MCF-7 human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

DNA topoisomerases as targets for anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Genistein and quercetin increase connexin43 and suppress growth of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Inhibition of human glutathione S-transferase P1-1 by the flavonoid quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Specific interactions of quercetin and other flavonoids with target proteins are revealed by elicited fluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Multitargeted cancer prevention by quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Quercetin down-regulates signal transduction in human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1596-X

10.1007/S00280-011-1596-X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

21400027